The Recall Desk
HighFDA (Drugs)·D-1636-2019·Announced 2019-08-14

RXQ Compounding Recalls Ascorbic Acid Injection Due to Crystallization

RXQ Compounding LLC is voluntarily recalling Ascorbic Acid 500 MG/ML Injection due to crystallization. The recall covers all lots within expiry distributed nationwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The FDA classified this as a Class II recall. Per the rubric, Class II recalls without specific reports of hospitalization or death typically fall into the High severity category, representing a risk of harm where injury has not yet been reported or is theoretically possible.

Plain-English summary

RXQ Compounding LLC has initiated a voluntary recall of Ascorbic Acid 500 MG/ML (Non-Corn) Injection, 50 mL per vial. The recall was initiated on June 19, 2019, and the product is identified by NDC 70731-0975-50. The recall covers all lots within their expiration dates.

The reason for the recall is crystallization in the product. The FDA classified this recall as Class II, which indicates a situation that may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The recall was initiated by the firm and notified via press release.

The product was distributed nationwide in the United States. The recall status is currently terminated as of September 16, 2022. Consumers and healthcare providers should check their inventory for this specific product and NDC number. If found, the product should be returned to the supplier or disposed of according to local regulations, as it is no longer in distribution.

The recalled product

Product
Ascorbic Acid 500 MG/ML (Non-Corn) INJ (MDV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0975-50
Manufacturer
RXQ Compounding LLC
Category
Drug — Injectable
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Related recalls

Same manufacturer · RXQ Compounding LLC

See all →

Same hazard · crystallization

See all →